Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin in Children With Steroid Sensitive Nephrotic Syndrome
NCT07320612Phase 1Completed
- Sponsor
- University of Child Health Sciences and Children's Hospital, Lahore
- Start
- Mar 2025
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of azithromycin in nephrotic syndrome (2 arms), sponsored by University of Child Health Sciences and Children's Hospital, Lahore. Primary endpoint: Early remission at 14 days. Started Mar 2025; status: completed.
02
Drugs
azithromycin
03
Conditions
nephrotic syndrome
Beyond the preview
Go deeper on NCT07320612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07320612.